Varubi
- Product NDC
- 69656-101
- 11-digit product format
- 696560101
- Labeler code
- 69656
- Product ID
- 69656-101_41a8662a-8aa7-4c63-8fc6-b29286e08ac8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- rolapitant
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- GlaxoSmithLine LLC
- Application
- NDA206500
- Marketing category
- NDA
- Marketing start
- 2015-10-07
- Marketing end
- 2021-10-31
- Substance
- ROLAPITANT HYDROCHLORIDE
- Active strength
- 90 mg/1
- Pharmacologic classes
- Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 2D6 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69656-101-02 | 69656010102 | 2 TABLET in 1 BLISTER PACK (69656-101-02) | 2 tablet | 2015-10-07 | 2021-10-31 | No | No | Current |